rs1554224412
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_080680.3(COL11A2):c.808_813delTCTCTCinsATTGGGCTCG(p.Ser270IlefsTer6) variant causes a frameshift, missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_080680.3 frameshift, missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 13Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- nonsyndromic genetic hearing lossInheritance: AD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
- otospondylomegaepiphyseal dysplasia, autosomal dominantInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive nonsyndromic hearing loss 53Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- otospondylomegaepiphyseal dysplasiaInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- otospondylomegaepiphyseal dysplasia, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- fibrochondrogenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| COL11A2 | NM_080680.3 | c.808_813delTCTCTCinsATTGGGCTCG | p.Ser270IlefsTer6 | frameshift_variant, missense_variant | Exon 6 of 66 | ENST00000341947.7 | NP_542411.2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| COL11A2 | ENST00000341947.7 | c.808_813delTCTCTCinsATTGGGCTCG | p.Ser270IlefsTer6 | frameshift_variant, missense_variant | Exon 6 of 66 | 5 | NM_080680.3 | ENSP00000339915.2 | 
Frequencies
GnomAD3 genomes  
GnomAD4 genome  
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Ser270fs variant in COL11A2 has not been previously reported in individuals with hearing loss, Stickler syndrome, or otospondylomegaepiphyseal dysplasia (OSMED). This va riant was absent from large population studies, though the ability of these stud ies to accurately detect indels may be limited. This variant is predicted to cau se a frameshift, which alters the protein?s amino acid sequence beginning at pos ition 270 and leads to a premature termination codon 6 amino acids downstream. T his alteration is then predicted to lead to a truncated or absent protein. Loss of function of the COL11A2 gene has been primarily associated with autosomal rec essive OSMED. However, this variant occurs in an alternately spliced exon in COL 11A2, and no disease-causing loss-of-function variants have been previously repo rted in this region. This may suggest that the exon is not essential to protein function or that this variant may not have an impact on the protein product due to alternate splicing. Therefore the impact, if any, of this variant upon the pr otein is uncertain. In summary, while there is some suspicion for a pathogenic r ole, the clinical significance of this variant is uncertain. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at